Skip to NavigationSkip to content

News

Takeda continues its mission to reduce its debt in the wake of its $49 billion acquisition of Shire in January last year, announcing that it will...
Moderna is to start testing 30,000 people with its coronavirus vaccine beginning in July, after progressing through various trials.
Mylan and Biocon have scored FDA approval with their insulin glargine injection Semglee, a biosimilar to Sanofi’s Lantus, in both pre-filled pen and...
The news this week continues to be dominated by breakthroughs in COVID-19 treatments, with a US clinical trial of the drug ivermectin finding that it...
Figures show that cancer care in England has faced major disruption due to a big drop in referrals from GPs because of the coronavirus pandemic,...
PTSD patients being treated with MDMA experience numerous beneficial effects that hold strong for well after a year after completing therapy,...
MSD has announced the disappointing findings that its anti-PD-1 immunotherapy Keytruda (pembrolizumab), when used either alone or combined with...
An antibody therapy for coronavirus could be available from Eli Lilly as early as September, according to one of its chief scientists.
AbbVie has joined forces with Genmab to develop and commercialise three of the latter’s early-stage Genmab drug products – epcoritamab (DuoBody-...
26 pharmaceutical companies are being sued by most US states for allegedly conspiring to reduce competition and drive up generic drug prices.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches